These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22810500)

  • 1. Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.
    Yadav HN; Singh M; Sharma PL
    Mol Cell Biochem; 2012 Oct; 369(1-2):227-33. PubMed ID: 22810500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.
    Yadav HN; Singh M; Sharma PL
    Mol Cell Biochem; 2010 Oct; 343(1-2):75-81. PubMed ID: 20512612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.
    Mittal D; Taliyan R; Sharma PL; Yadav HN
    Indian J Pharmacol; 2016; 48(1):59-63. PubMed ID: 26997724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
    Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
    J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.
    Kansal SK; Jyoti U; Sharma S; Kaura A; Deshmukh R; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):635-41. PubMed ID: 25743572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of zinc chloride and zinc ionophore pyrithione on attenuated cardioprotective potential of preconditioning phenomenon in STZ-induced diabetic rat heart.
    Jamwal S; Kumar K; Reddy BV
    Perfusion; 2016 May; 31(4):334-42. PubMed ID: 26423303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation.
    Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H922-30. PubMed ID: 21217064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition.
    Varela AT; Simões AM; Teodoro JS; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
    Mitochondrion; 2010 Aug; 10(5):456-63. PubMed ID: 20433952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3β/β-catenin signaling pathway in ischemic rat myocardium.
    Wu QL; Shen T; Shao LL; Ma H; Wang JK
    Shock; 2012 Aug; 38(2):165-9. PubMed ID: 22576003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
    Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning offers cardioprotection in hyperlipidemic rat hearts: possible role of Dopamine (D2) signaling.
    Gupta V; Goyal R; Sharma PL
    BMC Cardiovasc Disord; 2015 Jul; 15():77. PubMed ID: 26216101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3β.
    Zhou M; Ren H; Han J; Wang W; Zheng Q; Wang D
    Oxid Med Cell Longev; 2015; 2015():481405. PubMed ID: 26265983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.